CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Baxter International Inc   (BAX)
Other Ticker:  
 
 

BAX's Capital Expenditures Growth by Quarter and Year

Baxter International Inc 's Capital Expenditures results by quarter and year




BAX Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 190.00 200.00 235.00
III Quarter September - 174.00 168.00 179.00
II Quarter June 117.00 156.00 171.00 158.00
I Quarter March 182.00 172.00 140.00 171.00
FY   299.00 692.00 679.00 743.00



BAX Capital Expenditures second quarter 2024 Y/Y Growth Comment
Baxter International Inc reported fall in Capital Expenditures in the second quarter 2024 by -25% to $ 117.00 millions, from the same quarter in 2023.
The drop in the second quarter 2024 Baxter International Inc 's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures jump of 43.05%.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 38 other companies have achieved higher Capital Expenditures growth. While Baxter International Inc ' s Capital Expenditures drop of -25% ranks overall at the positon no. 912 in the second quarter 2024.


BAX Capital Expenditures ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - -5 % -14.89 % -0.84 %
III Quarter September - 3.57 % -6.15 % 14.74 %
II Quarter June -25 % -8.77 % 8.23 % 9.72 %
I Quarter March 5.81 % 22.86 % -18.13 % -0.58 %
FY   - 1.91 % -8.61 % 4.8 %

Financial Statements
Baxter International Inc 's second quarter 2024 Capital Expenditures $ 117.00 millions BAX's Income Statement
Baxter International Inc 's second quarter 2023 Capital Expenditures $ 156.00 millions Quarterly BAX's Income Statement
New: More BAX's historic Capital Expenditures Growth >>


BAX Capital Expenditures (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - 9.2 % 19.05 % 31.28 %
III Quarter September - 11.54 % -1.75 % 13.29 %
II Quarter June -35.71 % -9.3 % 22.14 % -7.6 %
I Quarter March -4.21 % -14 % -40.43 % -27.85 %
FY (Year on Year)   - 1.91 % -8.61 % 4.8 %


Suppliers by BAX Divisions >> Back to BAX Growth rate Comparisons >>


Capital Expenditures second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #102
Overall #912

Capital Expenditures Y/Y Growth Statistics
High Average Low
912.61 % 43.05 % -88.34 %
(Sep. 28. 2010)   (June 30. 2016)
Capital Expenditures second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #102
Overall #912
Capital Expenditures Y/Y Growth Statistics
High Average Low
912.61 % 43.05 % -88.34 %
(Sep. 28. 2010)   (June 30. 2016)

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Baxter International Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
126.32 % 4.8 % -100 %
(June 29, 2009)  


BAX's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2024 Baxter International Inc disclosed fall in Capital Expenditures from the previous quarter by -35.71% to $ 117.00 millions, from $ 182.00 millions released in the previous quarter.

This is not huge issue, as Baxter International Inc 's Capital Expenditures always tend to dip in this quarter Kayla Brown, Healthcare sector insider wrote.

Within Medical Equipment & Supplies industry 86 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Baxter International Inc 's Capital Expenditures growth quarter on quarter, overall rank is 2043.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #87
Healthcare Sector #261
Overall #2043
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #87
Healthcare Sector #261
Overall #2043
Capital Expenditures Q/Q Growth Statistics
High Average Low
126.32 % 4.8 % -100 %
(June 29, 2009)  


BAX's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2024 Baxter International Inc disclosed fall in Capital Expenditures sequentially by -35.71% to $ 117.00 millions, from $ 182.00 millions achived a quarter before.

As we evaluate current downturn in the quarter, we should presume, that frequently II. Quarter Capital Expenditures emerge softer in contrast to the preciding period

Within Medical Equipment & Supplies industry 86 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Baxter International Inc 's Capital Expenditures growth quarter on quarter, overall rank is 2043.


Baxter International Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)
Cumulative Capital Expenditures 12 Months Ending $ 663.00 $ 702.00 $ 692.00 $ 702.00 $ 696.00
Y / Y Capital Expenditures Growth (TTM) -4.74 % -1.27 % 1.91 % -1.68 % -4 %
Year on Year Capital Expenditures Growth Overall Ranking # 946 # 888 # 255 # 1152 # 1335
Seqeuential Capital Expenditures Change (TTM) -5.56 % 1.45 % -1.42 % 0.86 % -2.11 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1060 # 1111 # 1039 # 1457 # 1570

New: More BAX's historic Capital Expenditures Growth >>



Cumulative Capital Expenditures growth Comment
Baxter International Inc 's cumulative 12 months Capital Expenditures continue to decrease, but on the faster rate at -4.74% year on year, at Jun 30 2024 compare to the -1.27% decrease at Mar 31 2024. If the Baxter International Inc 's fiscal year would end at Jun 30 2024, annual Capital Expenditures would be $663 millions.

In the Healthcare sector 107 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 888 to 946.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
912.61 %
43.05 %
-88.34 %
(Sep. 28. 2010)  

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 39
Healthcare Sector # 108
Overall # 946

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
912.61 %
43.05 %
-88.34 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 107
S&P 500 # 1005
Cumulative Capital Expenditures growth Comment
Baxter International Inc 's cumulative 12 months Capital Expenditures continue to decrease, but on the faster rate at -4.74% year on year, at Jun 30 2024 compare to the -1.27% decrease at Mar 31 2024. If the Baxter International Inc 's fiscal year would end at Jun 30 2024, annual Capital Expenditures would be $663 millions.

In the Healthcare sector 107 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 888 to 946.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
912.61 %
43.05 %
-88.34 %
(Sep. 28. 2010)  


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 39
Healthcare Sector # 108
Overall # 946

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
912.61 %
43.05 %
-88.34 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 107
S&P 500 # 1005




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BAX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BAX's Competitors
Capital Expenditures Growth for Baxter International Inc 's Suppliers
Capital Expenditures Growth for BAX's Customers

You may also want to know
BAX's Annual Growth Rates BAX's Profitability Ratios BAX's Asset Turnover Ratio BAX's Dividend Growth
BAX's Roe BAX's Valuation Ratios BAX's Financial Strength Ratios BAX's Dividend Payout Ratio
BAX's Roa BAX's Inventory Turnover Ratio BAX's Growth Rates BAX's Dividend Comparisons



Companies with similar Capital Expenditures decrease for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jun 30 2024
Ufp Technologies Inc -0.04%$ -0.036 millions
Keros Therapeutics Inc -0.32%$ -0.322 millions
Inotiv Inc -1.40%$ -1.405 millions
Adapthealth Corp -1.62%$ -1.620 millions
The Pennant Group Inc -2.47%$ -2.471 millions
Prime Medicine Inc -3.74%$ -3.745 millions
Biomarin Pharmaceutical Inc-3.92%$ -3.920 millions
Integer Holdings Corporation-4.71%$ -4.712 millions
Orasure Technologies Inc-4.99%$ -4.994 millions
U S Physical Therapy Inc-5.19%$ -5.195 millions
Docgo Inc -5.30%$ -5.302 millions
Morphic Holding inc -6.14%$ -6.143 millions
Becton Dickinson And Company-6.28%$ -6.283 millions
Gilead Sciences Inc -6.47%$ -6.475 millions
Select Medical Holdings Corp-6.66%$ -6.664 millions
Owens and Minor inc -7.45%$ -7.454 millions
Omniab Inc -7.63%$ -7.626 millions
Ge Healthcare Technologies Inc -8.57%$ -8.571 millions
Align Technology inc -8.70%$ -8.703 millions
Beigene Ltd -9.48%$ -9.484 millions
Irhythm Technologies Inc -9.67%$ -9.673 millions
Iqvia Holdings Inc -10.63%$ -10.625 millions
Quest Diagnostics Inc-11.54%$ -11.538 millions
Amgen Inc -12.18%$ -12.177 millions
Cytek Biosciences Inc -12.21%$ -12.208 millions
Hims and Hers Health Inc -12.21%$ -12.209 millions
Caribou Biosciences Inc -12.22%$ -12.221 millions
Tandem Diabetes Care Inc -12.35%$ -12.349 millions
Neuronetics Inc -12.50%$ -12.500 millions
Viatris Inc -13.27%$ -13.274 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com